COVID-19 medical insurance cannot be reimbursed 100%, because only some drugs are included in the scope of medical insurance reimbursement, and policies in different regions are different, depending on local policies!

Patients with new pneumonia enjoy the special medical insurance reimbursement policy, and the drugs and medical services covered by the novel coronavirus infectious pneumonia diagnosis and treatment plan of the National Health and Wellness Committee are temporarily included in the payment scope of the medical insurance fund.

Legal basis:

Article 2 of the Notice on Doing a Good Job in Medical Security for novel coronavirus Epidemic ensures that patients are not affected by expenses.

First, the medical expenses incurred by the patients diagnosed with pneumonia in novel coronavirus shall be subsidized by the finance after the payment of basic medical insurance, serious illness insurance and medical assistance according to the regulations, and comprehensive protection shall be implemented.

Second, the patients who have been diagnosed with novel coronavirus should be treated first and then settled, and reimbursement should not be reduced.

Third, the drugs and medical services used by patients with pneumonia in novel coronavirus are in line with the diagnosis and treatment plan for pneumonia in novel coronavirus formulated by the health department, and can be temporarily included in the scope of medical insurance fund payment.